Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-03-25 00:00:00 ET · period of report 2023-03-25 · accession 0001415889-24-009068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | 2024-03-25 | FENC | Andrade Robert | CFO | S - Sale | $11.00 | -14.0K | 105.7K | -12% | -$153.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2024-03-25 | S | D | 13,975 | $11.00 | 105,746 | D | — | — | (F1) Represents shares sold pursuant to a 10b5-1 plan adopted on August 16, 2023. |